###begin article-title 0
###xml 52 53 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function
###end article-title 0
###begin p 1
A. la Sala and J. He contributed equally to this paper.
###end p 1
###begin p 2
###xml 238 256 238 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii.</italic>
###xml 353 354 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 593 594 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1242 1243 1226 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 238 255 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 919 924 <span type="species:ncbi:10090">mouse</span>
Prior studies have demonstrated that cholera toxin (CT) and other cAMP-inducing factors inhibit interleukin (IL)-12 production from monocytes and dendritic cells (DCs). We show that CT inhibits Th1 responses in vivo in mice infected with Toxoplasma gondii. This correlated with low serum IL-12 levels and a selective reduction in the numbers of CD8alpha+ conventional DCs (cDCs) in lymphoid organs. CT inhibited the function of interferon (IFN) regulatory factor (IRF) 8, a transcription factor known to positively regulate IL-12p35 and p40 gene expression, and the differentiation of CD8alpha+ and plasmacytoid DCs (pDCs). Fluorescence recovery after photobleaching analysis showed that exposure to CT, forskolin, or dibutyryl (db) cAMP blocked LPS and IFN-gamma-induced IRF8 binding to chromatin. Moreover, CT and dbcAMP inhibited the binding of IRF8 to the IFN-stimulated response element (ISRE)-like element in the mouse IL-12p40 promoter, likely by blocking the formation of ISRE-binding IRF1-IRF8 heterocomplexes. Furthermore, CT inhibited the differentiation of pDCs from fms-like tyrosine kinase 3 ligand-treated bone marrow cells in vitro. Therefore, because IRF8 is essential for IL-12 production and the differentiation of CD8alpha+ cDCs and pDCs, these data suggest that CT and other Gs-protein agonists can affect IL-12 production and DC differentiation via a common mechanism involving IRF8.
###end p 2
###begin p 3
###xml 544 545 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 547 548 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 696 697 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 780 781 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 791 792 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 880 881 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 1217 1218 1196 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 1454 1455 1433 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
Cholera toxin (CT) is composed of a monomeric A subunit (CTA) and a pentameric B subunit (CTB). After binding of CTB to cell surface gangliosides, CTA acts to catalyze the ADP ribosylation of the intracellular G protein subunit Gsalpha, which then dissociates from Gsbetagamma-dimer and activates adenylate cyclase. This results in the induction of cAMP and activation of cAMP-dependent protein kinase A. Enzymatically active CT, as well as other ligands that induce cAMP production, can inhibit the production of IL-12 from monocytes and DCs (1, 2). CT also inhibits expression of IL-12beta1 and -12beta2 receptors on activated T cells, suppresses the function of Th1 but not Th2 T cell clones (3), and drives the differentiation of Th2 and IL-10-producing Tr1 T cells in vitro (4). In vivo, CT inhibits the production of both IL-12 and IFN-gamma in mice given LPS systemically (5). Given orally with most soluble protein antigens, CT preferentially drives Th2 responses locally and systemically, which is associated with production of IgA and IgG1>IgG2a antibodies; and after repeated oral dosing, CT induces high IgE levels to coadministered antigens that results in anaphylaxis to subsequent antigenic challenge (6). Together with several additional effects on immune and nonimmune cells, the ability of CT to block IL-12 production and responsiveness likely contributes to its ability to drive Th2 responses when given orally with protein antigens (1).
###end p 3
###begin p 4
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 730 731 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 733 734 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
Although it has been reported that CTB alone can down-regulate IL-12 expression (7), its inhibitory potency is a fraction of that caused by CT holotoxin (5). This indicates that the ability of CT to suppress IL-12 production is primarily dependent on the enzymatically active A subunit, as is its ability to act as an adjuvant in vivo (1, 2). In addition, the suppression of IL-12 by ligand-mediated activation of Gs protein-coupled receptors, such as those for prostaglandin E2, histamine, beta2-adrenergic agonists, adenosine, cannabinoids, and opiates, as well as by the cell-permeable cAMP analogue dbcAMP, suggests that the direct induction of cAMP by Gs protein activation plays a key role in CT-mediated IL-12 suppression (1, 2). However, the downstream effects of Gs protein-induced cAMP on the signaling pathways required for IL-12 production are not clear.
###end p 4
###begin title 5
RESULTS AND DISCUSSION
###end title 5
###begin title 6
Gs protein-mediated inhibition of IL-12 production by cDCs
###end title 6
###begin p 7
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 435 436 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
Prior studies demonstrated the ability of CT to inhibit the production of IL-12 from human monocytes and monocyte-derived DCs (5). We initially determined whether this also applied to freshly isolated mouse conventional DCs (cDCs), and whether it extended to other Gs protein agonists. CT, as well as agonists for beta2-adrenergic receptor (salbutamol), and the adenosine A2a receptor (CGS 21680; 2-p-[2-Carboxyethyl] phenethylamino-5-N-ethylcarboxamidoadenosine hydrochloride) suppressed the production of both IL-12p40 and IL-12p70 from spleen cDCs stimulated with SAC and IFN-gamma (), whereas IL-10 production was not suppressed (unpublished data).
###end p 7
###begin title 8
###xml 57 74 57 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii</italic>
###xml 57 74 <span type="species:ncbi:5811">Toxoplasma gondii</span>
CT inhibits the production of IL-12 after infection with Toxoplasma gondii in vivo
###end title 8
###begin p 9
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 646 655 646 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 777 783 777 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 962 970 962 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1012 1020 1012 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1120 1128 1116 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 646 655 <span type="species:ncbi:5811">T. gondii</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
CT has been shown to induce Th2 responses after oral administration with soluble protein antigens; however, because CT is normally given with inactivated proteins, the extent to which CT can modify the helper T (Th) cell phenotype during the induction of strong Th1 responses, as occurs after infection with intracellular pathogens, is not clear. Furthermore, when given intranasally, or orally with less purified antigens, CT has been reported to induce Th1 and Th2 responses (8, 9). Therefore, we decided to test the ability of CT to modify Th1 responses in mice during systemic infection of BALB/c mice with a high dose of the ME-49 strain of T. gondii. In this model, mice develop IL-12-dependent Th1 responses that clear the infection with 100% survival (10). As shown in Fig. 1, systemic administration of CT during the course of infection resulted in 100% mortality with nearly identical kinetics to that occurring after systemic neutralization of IL-12 (Fig. 1 A). In addition, parasite loads were high (Fig. 1 B) and serum levels of IL-12 and IFN-gamma were suppressed in both CT and anti-IL-12-treated groups (Fig. 1 C), consistent with CT having a dominant inhibitory effect on IL-12 production and the induction of Th1 responses to this infection.
###end p 9
###begin p 10
###xml 115 124 111 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 0 135 0 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reduced IL-12 and IFN-&#947; production in CT-treated mice results in increased parasite burden and mortality after <italic>T. gondii</italic> infection.</bold>
###xml 183 192 179 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 564 573 558 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 115 124 <span type="species:ncbi:5811">T. gondii</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 183 192 <span type="species:ncbi:5811">T. gondii</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 564 573 <span type="species:ncbi:5811">T. gondii</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
Reduced IL-12 and IFN-gamma production in CT-treated mice results in increased parasite burden and mortality after T. gondii infection. (A) Survival rate of BALB/c mice infected with T. gondii. Mortality was monitored daily. Data shown were obtained from eight mice/group and are representative of three experiments producing similar results. (B) Parasite burden in the peritoneum was measured 5 d after infection. Results are presented as mean +/- SD of five mice/group and are representative of three independent experiments. (C) Serum cytokine production after T. gondii infection. Sera were harvested 5 d after infection. Data shown are given as mean +/- SD of 5 individual mice and are representative of three experiments that produced similar results. *, P </= 0.002.
###end p 10
###begin title 11
###xml 42 43 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CT treatment results in a loss of CD8alpha+ cDCs
###end title 11
###begin p 12
###xml 82 91 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 158 159 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 228 230 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 325 326 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 472 473 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 482 483 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 508 509 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 516 524 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 561 569 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 592 593 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1037 1038 1013 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1155 1156 1127 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 82 91 <span type="species:ncbi:5811">T. gondii</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
Although it is likely that a variety of cells produce IL-12 during infection with T. gondii in vivo, including macrophages (11) and neutrophils (12), CD8alpha+ cDCs are thought to be one major source of this essential cytokine (13). We therefore asked whether CT administration affects IL-12 production by cDC subsets in vivo. Although mice treated with CT showed a 20-30% reduction of total cell numbers in the spleen, there was a dramatic preferential reduction of CD11c+ CD8alpha+ cDCs compared with CD11b+ cDCs (Fig. 2 A) and other lymphocyte compartments (Fig. 2 B). The loss of CD8alpha+ cDCs was not caused by apoptosis (); was transient, with cell numbers returning to normal levels by day 6; and was dose dependent, with 5 microg of CT having maximal and 0.5 microg of CT having minimal effects (Fig. S3 B). Moreover, no difference in the viability of splenocytes or peripheral blood cells from CT-treated versus PBS-treated controls or CTB-treated mice was found (unpublished data). Treatment with CTB had no effect on CD8alpha+ cDC numbers (unpublished data), indicating that ADP ribosylate activity of CTA was required for the loss of CD8alpha+ cDCs.
###end p 12
###begin p 13
###xml 63 64 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 126 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT administration induces preferential loss of splenic CD8&#945;<sup>+</sup> cDCs without affecting other lymphocyte compartments in vivo.</bold>
###xml 255 256 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 279 280 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 308 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 312 313 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 321 322 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 356 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 365 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 383 384 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
CT administration induces preferential loss of splenic CD8alpha+ cDCs without affecting other lymphocyte compartments in vivo. Spleen cells were isolated from BALB/c mice 48 h after i.p. CT injection and analyzed by flow cytometry. (A) MACS-enriched CD11c+ spleen cells. CD8alpha+ cDCs were defined as CD11c+CD19-CD8alpha+. (B) Effect of CT on T cell (CD4+ and CD8+) and B cell (CD19+) populations. Data shown are representative of five experiments showing similar effects ().
###end p 13
###begin p 14
###xml 36 37 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 98 85 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 243 244 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 316 295 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 476 477 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 601 602 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 772 773 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 837 839 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 941 942 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 1119 1120 1079 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1128 1129 1088 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1154 1155 1114 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1200 1208 1160 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1345 1346 1301 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 98 <span type="species:ncbi:5811">T. gondii</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 307 316 <span type="species:ncbi:5811">T. gondii</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
The loss of IL-12-producing CD8alpha+ cDCs may contribute to the effects seen with CT in T. gondii infection. To address this issue more directly, we infected mice after treatment with 0.5 microg of CT, which has only minor effects on CD8alpha+ cDC numbers. At this dose, the effects of CT on the course of T. gondii infection were highly variable, yet in some experiments we observed a significant effect on survival and parasite load, despite only a minor change in CD8alpha+ cDC numbers (Fig. S3 and not depicted). To test the possibility that CT may affect IL-12 production independent of CD8alpha+ cDC loss, we gave graded doses of CT to mice, administered LPS systemically, and measured IL-12 and IFN-gamma levels in the serum. Prior studies have shown that CD8alpha+ cDCs are a significant source of IL-12 under these conditions (13), and that IFN-gamma production after LPS administration can be blocked with antibodies to IL-12p40 (5). We found that low doses of CT (0.5 microg) consistently suppressed both IL-12 and IFN-gamma production in response to LPS (Fig. S3). Furthermore, the total percentages of CD4+ and CD8+ T cells, as well as CD19+ B cells, were unchanged after CT treatment (Fig. 2 B). These studies suggest that systemic administration of CT has two dose-dependent effects in vivo, one resulting in the loss of CD8alpha+ cDCs and the other resulting in the inhibition of IL-12 production by DCs and possibly other cells.
###end p 14
###begin title 15
CT blocks IFN regulatory factor (IRF) 8-chromatin interactions
###end title 15
###begin p 16
###xml 29 34 <span type="species:ncbi:9606">human</span>
In our initial studies using human monocytes stimulated with LPS alone or LPS and IFN-gamma, CT had no effect on the activation of signaling molecules positively regulating IL-12 production, such as NF-kappaB, STAT-1, or the mitogen-activated protein kinases (MAPKs) p38 and JNK (unpublished data). In addition, CT had no effect on the activation of extracellular signal-regulated kinase MAPK, which is a known negative regulator of IL-12 expression (unpublished data). Moreover, CT treatment did not affect the surface expression of Toll-like receptor (TLR)-4 or IFN-gamma receptor on LPS-stimulated or unstimulated monocytes (unpublished data) or the IFN-gamma receptor signaling pathway, as IFN-gamma-induced up-regulation of HLA-DR and CD40 was unaffected (unpublished data).
###end p 16
###begin p 17
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 292 293 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 382 369 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 415 417 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 424 427 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 451 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 486 487 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 495 496 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 503 505 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 506 508 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 553 556 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 648 650 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 766 767 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 832 841 816 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 373 382 <span type="species:ncbi:5811">T. gondii</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 832 841 <span type="species:ncbi:5811">T. gondii</span>
We next focused our study on the effect of CT on the function of IRF8, which is a transcription factor expressed by DCs, macrophages, granulocytes, and B cells; it is a positive regulator of IL-12p35 and IL-12p40 transcription (14-17) and has a central role in the differentiation of CD8alpha+ cDC and plasmacytoid DC (pDC) populations. Furthermore, production of IL-12 in T. gondii infection is dependent on IRF8 (11). IRF8-/- mice lack the CD8alpha+ and pDCs, although they have CD11c+CD8alpha- cDCs (18-21). Moreover, in these mice, the residual IRF8-/- cDCs display impaired responsiveness to TLR-mediated signals and fail to produce IL-12p40 (18). Thus, IRF8 is essential for both IL-12 production by myeloid cells including cDCs and the development of CD8alpha+ cDCs that likely represent an IL-12-producing DC subsets during T. gondii infection.
###end p 17
###begin p 18
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 256 259 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 550 556 550 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1222 1228 1218 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1390 1405 1382 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, B and C</xref>
###xml 1660 1675 1648 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, E and F</xref>
###xml 1795 1810 1783 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, A and D</xref>
###xml 1851 1854 1839 1842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1944 1946 1932 1934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 2234 2236 2222 2224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 2453 2455 2441 2443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 2457 2459 2445 2447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
We initially studied the dynamic interaction of IRF8 with chromatin in live cells using fluorescence recovery after photobleaching (FRAP) analysis, a method that was recently applied to the study of IRF8-chromatin interactions (22). For these studies, IRF8-/- Tot2 cells were stably transduced with IRF8-GFP that localizes to the nucleus. In the nucleus, IRF8-GFP is present in two functionally distinct forms: a fraction of low-mobility IRF8 molecules engaged in interactions with chromatin and a pool of highly mobile, unbound IRF8. As depicted in Fig. 3, in untreated IRF8-transduced Tot2 cells, a small fraction of immobile chromatin-bound IRF8 molecules was present, and 80% of the initial fluorescence signal is recovered within 4 s after photobleaching. When cells were stimulated with LPS and IFN-gamma that favored IRF8-chromatin interaction, an increase in the immobile IRF8 pool, and a consequent reduction of the highly mobile unbound IRF8 fraction, occurred, resulting in significantly slower fluorescence recovery. In these samples, only 60% of the recovery occurred within the first 4 s of analysis, and the maximal recovery achieved was 70% of initial signal compared with 90% observed in untreated cells (Fig. 3, red vs. black line). Treatment with CT, but not CTB, before stimulation with LPS and IFN-gamma produced a recovery curve similar to that of unstimulated cells (Fig. 3, B and C). Similar to what we observed with CT, cells pretreated with the G protein-independent adenylate cyclase activator forskolin or the membrane-permeable cAMP analogue dbcAMP and stimulated with LPS and IFN-gamma displayed a quick recovery of fluorescence (Fig. 3, E and F). Importantly, treatment with CT, CTB, forskolin, or dbcAMP alone did not alter the kinetics of fluorescence recovery (Fig. 3, A and D). IRF8-GFP was not overexpressed in IRF8-/- Tot2 cells because levels were below those of endogenous IRF8 in a macrophage cell line (22). Collectively, these data indicate that increased levels of cAMP, secondary to CT-induced Gs protein ADP ribosylation, impair the ability of IRF8 to bind to chromatin, and therefore to interact with its target promoters. Interestingly, IRF8 amplifies the transcription of its own gene (23). Thus, the cAMP-dependent inhibition of IRF8 binding to its own promotor would lead to reduced IRF8 mRNA expression, a concept that is consistent with prior studies showing cAMP-dependent IRF8 mRNA down-regulation (24, 25).
###end p 18
###begin p 19
###xml 0 98 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cAMP-elevating agents reduce IRF8&#8211;chromatin interaction elicited by LPS and IFN-&#947; stimulation.</bold>
cAMP-elevating agents reduce IRF8-chromatin interaction elicited by LPS and IFN-gamma stimulation. IRF8-deficient myeloid progenitor Tot2 cells were transduced with IRF8-GFP, left untreated (untreated), or treated with LPS (1 microg/ml) and IFN-gamma (100 ng/ml) for 4 h (LPS+IFN-gamma), and subjected to FRAP analysis. Where indicated, cells were exposed to CT (20 ng/ml), CTB (20 ng/ml), forskolin (20 ng/ml), or dbcAMP (100 microM) for 1 h before LPS and IFN-gamma treatment. Data shown represent the mean fluorescence obtained from at least 15 independent acquisitions from a single experiment representative of three performed that yielded similar results. The response of cells treated with CT, CTB, or forskolin or dbcAMP alone is the same as that measured in untreated cells.
###end p 19
###begin title 20
CT inhibits IRF8 binding to the IL-12p40 promoter and its interaction with IRF1
###end title 20
###begin p 21
###xml 283 285 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 287 289 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 554 562 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 577 585 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 964 972 956 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 267 272 <span type="species:ncbi:10090">mouse</span>
IRF8 together with IRF1 has been reported to enhance IL-12p40 gene transcription induced by LPS and IFN-gamma by forming a heterocomplex that interacts with a cis-acting element resembling the ISRE (IFN-stimulated response element; ISRE-like) located in the IL-12p40 mouse promoter (15, 26). To assess if CT inhibits DNA-IRF8 interaction specifically at the level of the IL-12p40 promoter, we performed a DNA affinity binding assay using a biotinylated IL-12p40 promoter sequence containing the native ISRE-like element conjugated to streptavidin beads (Fig. 4 A). As shown in Fig. 4 B, IRF8 in nuclear extracts from RAW 264.7 cells stimulated with LPS and IFN-gamma bound to the probe-conjugated beads, and this binding was completely abrogated when cells were pretreated with CT, but not CTB. Moreover, a similar inhibitory effect was exerted by dbcAMP. Significantly reduced binding of IRF8 to a probe carrying a mutation in the ISRE-like element was observed (Fig. 4 B, lane 6) indicating that IRF8 binding was dependent on the integrity of the ISRE-like element.
###end p 21
###begin p 22
###xml 0 135 0 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT and dbcAMP reduce IRF8 binding to the ISRE-like region of the mouse IL-12p40 promoter and prevent IRF1&#8211;IRF8 heterocomplex formation.</bold>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 1040 1046 <span type="species:ncbi:9986">rabbit</span>
CT and dbcAMP reduce IRF8 binding to the ISRE-like region of the mouse IL-12p40 promoter and prevent IRF1-IRF8 heterocomplex formation. (A) Schematic representation of the -92 to +12 region of the mouse IL-12p40 promoter. The ISRE-like sequence is represented in bold. (B) CT and dbcAMP, but not CTB, inhibited IRF8, but not IRF1 or TFIIB, interaction with the mouse IL-12p40 promoter. A biotinylated DNA probe corresponding to the -81 to -24 region of the mouse IL-12p40 promoter encompassing the ISRE-like sequence, and a biotinylated mutant probe containing substitution (indicated by the lower case letters) in the context of the ISRE-like element were conjugated with streptavidin-bound magnetic beads and incubated with 500 microg of nuclear extracts from RAW 264.7 cells stimulated for 4 h as indicated. CT, CTB (both at 20 ng/ml), and dbcAMP (100 microM) were added 1 h before addition of LPS (1 microg/ml) and IFN-gamma (100 ng/ml). Bound material was eluted, separated by 10% SDS-PAGE, and detected by Western blot analysis using rabbit anti-IRF8 antibody. (C) CT or dbcAMP did not modify the total amount of IRF8 or IRF1 in the nucleus. 500 microg of nuclear extracts were analyzed to measure the presence of IRF8 or IRF1 by SDS-PAGE Western blot. Membranes were stripped and reblotted to verify equal protein loading using an antinucleolin antibody. (D) CT reduces IRF1-IRF8 heterocomplex formation induced by LPS and IFN-gamma. 1 mg of nuclear extract was immunoprecipitated with anti-IRF1 antibody and analyzed by Western blot for the presence of IRF8 or IRF1. (E) Tyrosine phosphorylation of IRF1 is not affected by CT. 1 mg of nuclear extracts was immunoprecipitated with antiphosphotyrosine antibody and analyzed by Western blot for the presence of IRF1. Data shown are representative of at least three experiments.
###end p 22
###begin p 23
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 770 778 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
The same ISRE-like element is a consensus sequence for IRF1 (26), therefore we investigated the effect of CT or dbcAMP on the ability of IRF1 to interact with the IL-12p40 promoter. Similar to IRF8, stimulation with LPS and IFN-gamma induced IRF1 binding; however, neither CT nor dbcAMP reduced such interaction. Moreover, binding of TFIIB, a component of the RNA polymerase II complex, to the TATA box element included in the probe sequence, was unaffected by CT treatment, indicating that the inhibition exerted by CT and dbcAMP was specific for IRF8. Moreover, similar levels of IRF8 and IRF1 were detected in nuclear extracts of all cells stimulated with LPS and IFN-gamma, indicating that observed effects were not caused by reduced IRF8 expression in the nucleus (Fig. 4 C).
###end p 23
###begin p 24
###xml 352 360 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 448 450 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 549 557 541 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
The concomitant ability of IRF1 and inability of IRF8 to bind to the IL-12p40 promoter in cells treated with CT or dbcAMP prompted us to determine whether CT treatment could inhibit the formation of the IRF1-IRF8 heterocomplex. Consistent with this possibility, CT markedly reduced the amount of nuclear IRF1-IRF8 complex induced by LPS and IFN-gamma (Fig. 4 D). Tyrosine phosphorylation of IRF1 is a crucial event for IRF1-IRF8 complex formation (27). However, the amount of phosphorylated IRF1 induced by LPS and IFN-gamma was not modified by CT (Fig. 4 E). This indicates that the ability of CT to block IRF1-IRF8 complex formation is not caused by impaired IRF1 phosphorylation.
###end p 24
###begin p 25
###xml 177 178 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 540 542 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 1145 1147 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
Together with IL-12 suppression, CT can enhance the ability of TLR ligands to induce DC production of IL-6, IL-1beta, and IL-10, while inhibiting their production of TNF-alpha (4). We confirmed the ability of CT and dbcAMP to inhibit the production of IL-12 and TNF-alpha, but not IL-10, in human peripheral blood monocytes, monocyte-derived DCs, and the RAW 264.7 cell line stimulated with LPS and IFN-gamma (). Interestingly, recent data indicate that TNF-alpha gene transcription in mouse macrophages is also regulated by IRF1 and IRF8 (28). Therefore, it is feasible that the mechanism by which CT and cyclic AMP blocks TNF-alpha production is also caused by effects on IRF1-IRF8 interactions. The molecular events triggered by CT that lead to reduced IRF1-IRF8 interaction remain unclear. In addition to IRF1, IRF8 has been reported to form heterocomplexes with other binding partners, including NFAT and PU.1. Interference with physical interaction between these proteins and IRF8 might regulate its ability to associate with DNA and IRF1. In support of this possibility, increased cAMP levels have been reported to inhibit NFAT activity (29). PKA-dependent phosphorylation of NFAT increased 14-3-3 binding and reduced NFAT transcription activity at the IL-2 promotor. Whether CT and other cAMP inducers might affect such interactions is currently under investigation in our laboratories.
###end p 25
###begin title 26
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
CT blocks the differentiation of pDCs from bone-marrow cells cultured with fms-related tyrosine kinase 3 ligand (FLT-3L) in vitro and mouse spleen cells in vivo
###end title 26
###begin p 27
###xml 294 295 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 321 323 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 324 326 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 453 455 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 690 691 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 697 698 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 782 790 778 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 861 862 857 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 867 868 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 937 938 933 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 943 944 939 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1001 1002 997 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1007 1008 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1031 1039 1027 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 1120 1128 1116 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 1271 1272 1263 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1336 1344 1328 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 641 646 <span type="species:ncbi:10090">mouse</span>
Results of the FRAP analysis indicate that CT induces a general inhibition of IRF8 function, suggesting that other IRF8-dependent processes might also be affected. IRF8 plays a key role not only in the activation of IL-12p35 and p40 genes, but also in the normal development of pDC and CD8alpha+ cDC populations in vivo (18-21). Moreover, IRF8-deficent bone marrow cells fail to differentiate into pDCs when cultured in the presence of FLT-3L in vitro (21). We therefore studied the effect of CT on the generation of pDCs from FLT-3L-stimulated bone marrow cultures. In keeping with previous reports, after culture with FLT-3L, one third of mouse bone marrow cells differentiated into CD11c+ CD11b- cells that also expressed B220 and Ly6c and could therefore be identified as pDCs (Fig. 5 A). In the presence of CT, we observed a dramatic reduction of the CD11c+CD11b- subset (from 34.6 to 4.28%), and a concomitant increase in the CD11c+CD11b+ population. In addition, only 50% of the remaining CD11c+CD11b- cells expressed Ly6C (Fig. 5 B). Conversely, exposure to CTB did not alter FLT-3L-induced pDC differentiation (Fig. 5 C), indicating that this effect of CT is dependent on the CTA activity. Consistent with these results, and similar to our findings with CD8alpha+ DCs, pDCs were preferentially lost after CT treatment in vivo (Fig. 5 D). The ability of CT to inhibit the differentiation of pDCs from FLT-3L-treated bone marrow and to induce pDC depletion in vivo is consistent with the hypothesis that IRF8-DNA interaction is a major target of CT activity.
###end p 27
###begin p 28
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT, but not CTB, blocks pDC differentiation in vitro and in vivo.</bold>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 602 603 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 607 608 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 615 616 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 620 621 616 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
CT, but not CTB, blocks pDC differentiation in vitro and in vivo. (A-C) Bone marrow from BALB/c mice femurs was cultured in the presence of 100 ng/ml rh-FLT-3L with or without CT or CTB (both at 20 ng/ml). Medium was changed at day 3 and 6 of culture and fresh FLT-3L and CT or CTB was added. After 9 d, cells were harvested and subjected to flow cytometry to determine their phenotype. pDCs were defined as CD11c+CD11b-B220+Ly6C+. (A) Untreated. (B) CT treated. (C) CTB treated. (D) Total spleen cells from mice injected with 5 microg of CT i.p. were harvested 48 h later. pDCs are identified as CD11c+CD19-mPDCA-1+Ly6C+ cells. Data shown is representative of four experiments yielding similar results.
###end p 28
###begin p 29
###xml 100 109 100 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 697 698 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 100 109 <span type="species:ncbi:5811">T. gondii</span>
In summary, our findings indicate that CT can inhibit IL-12 production in vivo after infection with T. gondii, or systemic administration of LPS. In addition, we identify the inhibition of IRF8 function as a major molecular mechanism by which CT and other cAMP-inducing agents prevent IL-12 production in vitro and in vivo. Furthermore, we demonstrate that the CT-induced block of IRF8 function is associated with impaired IRF1-IRF8 heterocomplex formation that is independent of the phosphorylation state of IRF1. Finally, by blocking IRF8 function, CT may simultaneously inhibit IL-12p40 mRNA expression in macrophages and differentiated DCs and interfere with normal differentiation of CD8alpha+ DCs (and pDCs) that represent a primary source of IL-12, at least under certain stimulation conditions.
###end p 29
###begin title 30
MATERIALS AND METHODS
###end title 30
###begin title 31

###end title 31
###begin title 32
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and cell lines.
###end title 32
###begin p 33
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
8-12-wk-old conventionally housed female BALB/c mice were obtained from the National Cancer Institute and were used as approved under animal study protocol LMI11E by the National Institute of Allergy and Infectious Disease/National Institutes of Health (NIH) Animal Care and Use Committee. The derivation and maintenance of IRF8-/- Tot2 cells and their transfection with IRF8-GFP were previously described (30). The mouse macrophage cell line RAW 264.7 was purchased from American Type Culture Collection (ATCC).
###end p 33
###begin title 34
Cell culture and measurement of cytokines.
###end title 34
###begin p 35
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 504 505 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 860 861 842 843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 949 970 931 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 1096 1112 1074 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 97 102 <span type="species:ncbi:9606">Human</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
###xml 424 429 <span type="species:ncbi:10090">mouse</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 949 970 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 1048 1053 <span type="species:ncbi:10090">mouse</span>
###xml 1096 1112 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1187 1192 <span type="species:ncbi:10090">mouse</span>
###xml 1406 1411 <span type="species:ncbi:10090">mouse</span>
CD11c+ splenocytes were isolated using anti-mouse-CD11c immunomagnetic beads (Miltenyi Biotech). Human monocytes were obtained by counterflow centrifugation-elutriation of blood collected from normal blood donors under the NIH Institutional Review Board-approved human subjects protocol 99-cc-0168. Monocyte-derived DCs were obtained by culturing purified human monocytes in GMCSF and IL-4, as previously described (5). The mouse macrophage cell line RAW 264.7 was and stimulated at 80% confluence. CD11c+ splenocytes, human blood monocytes, monocyte-derived DCs (Mo-DC), or the RAW 264.7 cells were cultured at 1-2 x 106 cells/ml in RPMI-1640 and supplemented with 10% FCS, 100 microg/ml penicillin, 100 microg/ml streptomycin, 50 microg/ml gentamicin, 5% NCTC-109 media (all from Invitrogen), 15 mM Hepes, and 200 mM glutamine (cRPMI) at 37degreesC and 5% CO2 with various stimuli as indicated. CT was purchased from List Biological Laboratories. Staphylococcus aureus, Cowan's strain I (SAC; Pansorbin) was obtained from Calbiochem. Recombinant mouse IFN-gamma was obtained from BD. LPS (from Escherichia coli, serotype 0127:B8) and salbutamol were purchased from Sigma-Aldrich. Anti-mouse-IL-12 (clone C17.6) was originally provided by G. Trinchieri (National Cancer Institute, Bethesda, MD). CGS21680 and ZM241385 were obtained from Tocris Bioscience. Cytokine levels in cell culture supernatants and mouse sera were measured by ELISA using standard kits (BD). ELISA lower limit of detection was 50 pg/ml for IFN-gamma and IL-12 p70 and 30 pg/ml for IL-12 p40.
###end p 35
###begin title 36
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 0 9 <span type="species:ncbi:5811">T. gondii</span>
T. gondii infection.
###end title 36
###begin p 37
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 495 504 491 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 0 9 <span type="species:ncbi:5811">T. gondii</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">Mice</span>
###xml 495 504 <span type="species:ncbi:5811">T. gondii</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
T. gondii cysts (ME-49 strain) were prepared from brains of infected mice as previously described (31). BALB/c mice were untreated or treated with two doses of CT (5 microg) or anti-IL-12 antibody (1.8 mg) given i.p. at 3-d intervals. Mice were infected with 100 cysts given i.p. 1 d after the first dose of CT or anti-IL-12. The percentage of infected peritoneal exudate cells was determined using stained cytospin preparations. 500 cells were counted for each sample. 5 d after infection with T. gondii, blood was collected from individual mice for cytokine quantification.
###end p 37
###begin title 38
FACS analysis.
###end title 38
###begin p 39
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Spleen cells, or CD11c+ enriched splenocytes were analyzed by flow cytometry using antibodies for cDCs (anti-CD11c, HL3), B cells (anti-CD19, 1D3), T cells (anti-CD3, 145-2C11, anti-CD4, GK1.5, anti-CD8, Ly-2), and pDCs (anti-B220, RA3-6B2, anti-Ly-6C, AL-21, mPDCA-1, JF05-1C2.4.1; all from BD). Labeled cells were analyzed using a FACSCalibur flow cytometer (BD), and data was analyzed using FlowJo software (Tree Star, Inc.).
###end p 39
###begin title 40
FRAP.
###end title 40
###begin p 41
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 1146 1148 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
FRAP for IRF8-chromatin interactions was performed on IRF8-GFP-transduced IRF8-/- Tot2 cells as previously described (22). Tot2 cells plated on a chambered coverslip in 1% methylcellulose (MethoCult; Stem Cell Technologies) were kept at 37degreesC by using an air stream stage incubator (ASI 400; Nevtek). Live-cell imaging was performed on a 510 confocal microscope (Carl Zeiss, Inc.) by using the 488-nm line of an Ar laser with a 100x, 1.3-numerical aperture oil immersion objective. Photobleaching was performed on a small circular area (0.5-microm radius, 25 pixels) in the nucleus at the maximum laser power. 30 prebleach images were acquired before a bleach pulse of 115 ms. Fluorescence recovery was monitored at low laser intensity (0.2% of a 45-mW laser) at 45-ms intervals for 16 s. FRAP experiments were performed on at least 15 independent cells, and data were averaged to generate a single FRAP curve. FRAP data obtained using cells before and after stimulation with LPS+IFN-gamma were analyzed to fit to the recently developed mathematical binding models to confirm and support our initial hypothesis on the two fractions of IRF8 (32).
###end p 41
###begin title 42
DNA affinity binding assay and immunoprecipitation.
###end title 42
###begin p 43
###xml 196 202 <span type="species:ncbi:10090">murine</span>
###xml 579 585 <span type="species:ncbi:9913">bovine</span>
###xml 1118 1124 <span type="species:ncbi:9986">rabbit</span>
###xml 1407 1412 <span type="species:ncbi:10090">mouse</span>
###xml 1692 1698 <span type="species:ncbi:9986">rabbit</span>
###xml 1712 1718 <span type="species:ncbi:9986">rabbit</span>
###xml 1795 1800 <span type="species:ncbi:10090">mouse</span>
###xml 2216 2222 <span type="species:ncbi:9986">rabbit</span>
Nuclear extracts from RAW 264.7 cells were obtained using NE-PER extraction kit following manufacturer's instructions. 5'-Biotin-labeled DNA sequence corresponding to the -81 to -24 region of the murine IL-12p40 promoter containing a known ISRE-like element, as well as a control sequence containing a substitution mutation in the region of the ISRE-like element were purchased from Invitrogen. Biotin-labeled probes were conjugated to 200 microg of streptavidin-coated magnetic beads (Dynabeads M-280 streptavidin; Dynal) in Tris-EDTA buffer (pH 7.9) and were blocked with 0.5% bovine serum albumin in TGED buffer (10 mM Tris-HCl, pH 8.0, 10% vol/vol glycerol, 0.1 mM ethylenediaminetetraacetic acid, and 0.01% Triton X-100) overnight at 4degreesC. The mixtures of probe-conjugated beads and 500 microg of nuclear extracts in 500 microl of TGED with the final concentration of NaCl at 100 mM were subsequently incubated at 4degreesC for 4 h. Beads were extensively washed with TGED buffer, and DNA-bound proteins were eluted using TGED with 1 M NaCl. Proteins were separated by SDS-PAGE for immunoblot detection with rabbit anti-IRF8 antibody. For coimmunoprecipitations, 500 microg of nuclear extracts from RAW264.7 cells diluted 1:3 with wash buffer (50 mM Tris-HCl, 1 mM PMSF, Complete protease inhibitor cocktail [Roche], and phosphatase inhibitor cocktail 1 and 2 [Sigma-Aldrich]) were incubated with mouse monoclonal anti-IRF1 (2.5 microg/sample; Santa Cruz Biotechnology, Inc.) or irrelevant IgG over night at 4degreesC in a rotator and recovered with 25 microl of G protein-conjugated magnetic beads (Active Motifs). Samples were subjected to SDS-PAGE and Western blot analysis with rabbit anti-IRF8 or rabbit anti-IRF1 (Santa Cruz Biotechnology). For determining IRF1 phosphorylation, mouse anti-phosphotyrosine monoclonal cocktail (5 microl/sample, 4G10; Millipore) or 2.5 microg of irrelevant IgG were incubated overnight at 4degreesC with 25 microl G protein-conjugated magnetic beads. Beads were then washed twice with ice-cold PBS and incubated (90 min at 4degreesC in a rotator) with 1 mg of nuclear extract. After extensive washing, samples were subjected to SDS-PAGE and Western blot analysis with rabbit anti-IRF1 antibody (Santa Cruz Biotechnology, Inc.).
###end p 43
###begin title 44
Bone marrow-derived pDCs.
###end title 44
###begin p 45
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 119 125 <span type="species:ncbi:9913">bovine</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
Bone marrow from 6-wk-old mice was cultured at 5 x 105 cells/ml in D-MEM (Biofluids, Inc.) supplemented with 10% fetal bovine serum and containing 100 ng/ml recombinant human FLT-3L (PeproTech). Medium together with FLT-3L was changed at days 3 and 6 of culture. CT or CTB was added at 20 ng/ml final concentration at the beginning of the culture and at every medium change. After 9 d, cells were analyzed by flow cytometry using fluorochrome-conjugated monoclonal antibodies against CD11c, CD11b, B220, and Ly6C (BD).
###end p 45
###begin title 46
Statistical analysis.
###end title 46
###begin p 47
###xml 124 125 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Results represent the mean +/- SD where applicable. Statistical significance of differences was determined by the Student's t test.
###end p 47
###begin title 48
Online supplemental material.
###end title 48
###begin p 49
###xml 84 85 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 258 259 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 310 311 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 404 405 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 67 <span type="species:ncbi:10090">murine</span>
###xml 569 574 <span type="species:ncbi:9606">human</span>
Fig. S1 demonstrates the regulation of IL-12 production from murine cDCs by the beta2 adrenergic agonist Salbutamol, the adenosine A2a receptor agonist CGS21680, the adenosine A2a receptor antagonist ZM241385 and CT. Fig. S2 shows the time course of CD8alpha+ cDC loss as well as annexin V staining of CD8alpha+ cDCs after CT administration in vivo. Fig. S3 demonstrates the effect of CT dose on CD8alpha+ DC loss, and the effect on IL-12 and IFN-gamma production in vivo. Fig. S4 demonstrates the effect of CT and dbcAMP on IL-12, TNF-alpha, and IL-10 production from human monocytes, monocyte-derived DCs, and RAW 264.7 cells. Online supplemental material is available at .
###end p 49
###begin title 50
Supplementary Material
###end title 50
###begin title 51
[Supplemental Material Index]
###end title 51
###begin p 52
This work was supported by research funds from the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health.
###end p 52
###begin p 53
The authors have no conflicting financial interests.
###end p 53
###begin article-title 54
Regulation of interleukin-12 production by G-protein-coupled receptors.
###end article-title 54
###begin article-title 55
Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges.
###end article-title 55
###begin article-title 56
Cholera toxin discriminates between T helper 1 and 2 cell receptor-mediated activation: role of cAMP in T cell proliferation.
###end article-title 56
###begin article-title 57
Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent.
###end article-title 57
###begin article-title 58
Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta 1 and beta 2 chain expression.
###end article-title 58
###begin article-title 59
###xml 2 8 <span type="species:ncbi:10090">murine</span>
###xml 31 34 <span type="species:ncbi:9913">cow</span>
A murine model of IgE-mediated cow's milk hypersensitivity.
###end article-title 59
###begin article-title 60
###xml 83 89 <span type="species:ncbi:10090">murine</span>
Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
###end article-title 60
###begin article-title 61
###xml 23 40 23 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii</italic>
###xml 23 40 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.
###end article-title 61
###begin article-title 62
###xml 45 62 45 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii</italic>
###xml 45 62 <span type="species:ncbi:5811">Toxoplasma gondii</span>
Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.
###end article-title 62
###begin article-title 63
Cytokine regulation of immunopathology in toxoplasmosis.
###end article-title 63
###begin article-title 64
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.
###end article-title 64
###begin article-title 65
Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection.
###end article-title 65
###begin article-title 66
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas.
###end article-title 66
###begin article-title 67
An IFN-{gamma}-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.
###end article-title 67
###begin article-title 68
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages.
###end article-title 68
###begin article-title 69
###xml 18 24 <span type="species:ncbi:10090">murine</span>
Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP.
###end article-title 69
###begin article-title 70
Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein.
###end article-title 70
###begin article-title 71
###xml 131 132 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha+ dendritic cells.
###end article-title 71
###begin article-title 72
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells.
###end article-title 72
###begin article-title 73
ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro.
###end article-title 73
###begin article-title 74
Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells.
###end article-title 74
###begin article-title 75
Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages.
###end article-title 75
###begin article-title 76
###xml 67 73 <span type="species:ncbi:10090">murine</span>
Regulation of IFN consensus sequence binding protein expression in murine macrophages.
###end article-title 76
###begin article-title 77
###xml 27 47 27 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 27 47 <span type="species:ncbi:520">Bordetella pertussis</span>
Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
###end article-title 77
###begin article-title 78
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 0 20 <span type="species:ncbi:520">Bordetella pertussis</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.
###end article-title 78
###begin article-title 79
Identification of IFN regulatory factor-1 binding Site in IL-12 p40 gene promoter.
###end article-title 79
###begin article-title 80
Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA.
###end article-title 80
###begin article-title 81
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
IFN-{gamma}-induced TNF-{alpha} expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages.
###end article-title 81
###begin article-title 82
Integration of calcium and cyclic AMP signaling pathways by 14-3-3.
###end article-title 82
###begin article-title 83
ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages.
###end article-title 83
###begin article-title 84
###xml 103 120 <span type="species:ncbi:5811">Toxoplasma gondii</span>
Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.
###end article-title 84
###begin article-title 85
Analysis of binding reactions by fluorescence recovery after photobleaching.
###end article-title 85
###begin p 86
Abbreviations used: cDC, conventional DC; CT, cholera toxin; CTA, CT A subunit; CTB, CT B subunit; FLT-3L, fms-related tyrosine kinase ligand; FRAP, fluorescence recovery after photobleaching; IRF, IFN regulatory factor; ISRE, IFN-stimulated response element; pDC, plasmacytoid DC; TLR, Toll-like receptor.
###end p 86

